| Literature DB >> 24845217 |
Emanuela Locci1, Paola Scano2, Maria Francesca Rosa3, Matteo Nioi3, Antonio Noto4, Luigi Atzori1, Roberto Demontis3, Fabio De-Giorgio5, Ernesto d'Aloja3.
Abstract
The purpose of this study was to evaluate the feasibility of a (1)H-NMR-based metabolomic approach to explore the metabolomic signature of different topographical areas of vitreous humor (VH) in an animal model. Five ocular globes were enucleated from five goats and immediately frozen at -80 °C. Once frozen, three of them were sectioned, and four samples corresponding to four different VH areas were collected: the cortical, core, and basal, which was further divided into a superior and an inferior fraction. An additional two samples were collected that were representative of the whole vitreous body. (1)H-NMR spectra were acquired for twenty-three goat vitreous samples with the aim of characterizing the metabolomic signature of this biofluid and identifying whether any site-specific patterns were present. Multivariate statistical analysis (MVA) of the spectral data were carried out, including Principal Component Analysis (PCA), Hierarchical Cluster Analysis (HCA), and Partial Least Squares Discriminant Analysis (PLS-DA). A unique metabolomic signature belonging to each area was observed. The cortical area was characterized by lactate, glutamine, choline, and its derivatives, N-acetyl groups, creatine, and glycerol; the core area was characterized by glucose, acetate, and scyllo-inositol; and the basal area was characterized by branched-chain amino acids (BCAA), betaine, alanine, ascorbate, lysine, and myo-inositol. We propose a speculative approach on the topographic role of these molecules that are mainly responsible for metabolic differences among the as-identified areas. (1)H-NMR-based metabolomic analysis has shown to be an important tool for investigating the VH. In particular, this approach was able to assess in the samples here analyzed the presence of different functional areas on the basis of a different metabolite distribution.Entities:
Mesh:
Year: 2014 PMID: 24845217 PMCID: PMC4028277 DOI: 10.1371/journal.pone.0097773
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1A) An example of a sectioned frozen ocular globe; B) schematic representation of the four VH withdrawal areas: A, B, C, and D.
Figure 2Representative 1H-NMR spectrum of a VH sample with main resonance assignments.
Figure 3PCA score plots of 1H-NMR VH sample spectral data.
A) PC1 vs. PC2; B) PC2 vs. PC3. The explained variance is reported in brackets. Numbers represent eye samples, letters represent topographic areas, and W stands for the entire VH (A green circles; B blue squares; C red up-pointing triangles; D yellow down-pointing triangles, W light blue diamonds). Ellipse indicates the 95% Hotelling T2 confidence region. Samples with the same number and letter are duplicates.
Figure 4HCA of sample distribution in the PC2 vs. PC3 score space. A tree sorted by Ward clustering.
The vertical axis reports sample distances.
Variables with VIP >1 and the corresponding regression coefficients for each VH area as calculated by PLS-DA.
| Area | Variables | Coefficient values | Metabolites | ||
| A | B | C–D | |||
|
| 4.12 | 0.21 | −0.24 | 0.02 | Lactate |
| 4.16 | 0.20 | −0.23 | 0.02 | Lactate | |
| 2.48 | 0.12 | −0.06 | −0.05 | Glutamine | |
| 2.44 | 0.11 | −0.03 | −0.07 | Glutamine | |
| 3.24 | 0.10 | −0.05 | −0.04 | Cho, PCho, GPCho | |
| 2.04 | 0.10 | −0.01 | −0.07 | N-Acetyl groups | |
| 2.16 | 0.09 | −0.12 | 0.02 | Glutamine | |
| 3.96 | 0.09 | 0.01 | −0.09 | Creatine | |
| 2.08 | 0.08 | −0.01 | −0.06 | N-Acetyl groups | |
| 3.6 | 0.07 | 0.00 | −0.06 | Glycerol | |
|
| 3.52 | −0.04 | 0.15 | −0.10 | Glucose |
| 3.48 | −0.04 | 0.14 | −0.09 | Glucose | |
| 3.92 | −0.05 | 0.13 | −0.07 | Glucose | |
| 3.88 | 0.03 | 0.12 | −0.13 | Glucose | |
| 3.84 | 0.00 | 0.10 | −0.08 | Glucose | |
| 1.96 | 0.02 | 0.09 | −0.10 | Acetate | |
| 3.4 | −0.02 | 0.08 | −0.06 |
| |
| 3.72 | −0.01 | 0.08 | −0.06 | Glucose | |
|
| 1.00 | −0.18 | −0.02 | 0.18 | BCAA† |
| 1.04 | −0.16 | −0.02 | 0.15 | BCAA | |
| 3.28 | −0.15 | −0.02 | 0.15 | Betaine | |
| 0.96 | −0.12 | −0.01 | 0.12 | BCAA | |
| 1.52 | −0.07 | −0.07 | 0.12 | Alanine | |
| 1.08 | −0.12 | 0.00 | 0.11 | BCAA | |
| 4.04 | −0.05 | −0.07 | 0.10 | Ascorbate | |
| 1.48 | −0.04 | −0.08 | 0.10 | Alanine | |
| 3.76 | −0.08 | −0.03 | 0.09 | Ascorbate | |
| 1.76 | −0.11 | 0.00 | 0.09 | Lysine | |
| 1.72 | −0.10 | 0.00 | 0.08 | Lysine | |
| 3.64 | 0.00 | −0.09 | 0.07 |
| |
| 3.32 | 0.01 | −0.06 | 0.04 |
| |
Higher regression coefficient values indicate higher comparative levels of the corresponding metabolite in the VH area. Attribution of variables to specific metabolites is also reported.
*Cho (Choline), PCho (Phosphocholine), GPCho (Glycerophosphocholine); †BCAA (Branched Chain Amino Acids).
Figure 5Plot of PLS-DA variable regression coefficients in the three topographical areas: A, B, C–D.